Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 17
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do dolphins sleep at depth while swimming?

    All animals sleep, but cetaceans engage in unihemispherical sleep, where brainwaves show that only half...

    Performance-enhancing substances: How do male black widows use chemical cues to gain a competitive advantage?

    For a male black widow spider, life is a series of deadly challenges. He must first make a dangerous...

    Understanding How Mosquitoes are Repelled by DEET

    The recent zika outbreak highlights the importance of personal mosquito protection. The chemical DEET has...

    Backer Badge Funded